Evidence map›Paper›PMID 32837521›Full record

ReviewInternational journal of environmental science and technology : IJEST2020

The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemic.

Y R Rastogi, A Sharma, R Nagraik, A Aygün, F Şen

Abstract readReview
In one paragraph

Review in International journal of environmental science and technology : IJEST, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Insight of smart biosensors for COVID-19: A review.Luminescence : the journal of biological and chemical luminescence · 2023
    Review
  3. Urban air quality changes resulting from the lockdown period due to the COVID-19 pandemic.International journal of environmental science and technology : IJEST · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Malleability of the SARS-CoV-2 3CL MStructure (London, England : 1993) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Y R RastogiFaculty of Applied Sciences and Biotechnology, Shoolini University, Solan, Himachal Pradesh 173229 India.
A SharmaFaculty of Applied Sciences and Biotechnology, Shoolini University, Solan, Himachal Pradesh 173229 India.
R NagraikFaculty of Applied Sciences and Biotechnology, Shoolini University, Solan, Himachal Pradesh 173229 India.
A AygünSen Research Group, Biochemistry Department, Faculty of Arts and Science, Dumlupınar University, Evliya Çelebi Campus, 43100 Kütahya, Turkey.
F ŞenSen Research Group, Biochemistry Department, Faculty of Arts and Science, Dumlupınar University, Evliya Çelebi Campus, 43100 Kütahya, Turkey.ORCID 0000-0001-6843-9026

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel coronavirus strain 2019-nCoV has caused a rapid global pandemic-COVID-19. Scientists have taken onto the task of characterizing this new virus and understanding how this virus has transmitted to humans. All preliminary studies have found some striking similarities between this new virus and the SARS-CoV that caused a similar kind of epidemic in 2002-2003. Through bioinformatics tools, a great deal of information has been gathered about the origin, evolution and zoonosis of this virus. We, in this review, report the symptoms, mode of transmission and available and putative treatments to tackle 2019-nCoV infections. We also comprehensively summarize all the information so far made available regarding the genome, evolution and zoonosis of this virus.

Indexed as

2019-nCoVCOVID-19Homologous recombinationorf1a/bPhylogenetic analysisRdRp enzymeReceptor binding domain (RBD)Spike glycoprotein

Identifiers

PMID32837521
PMCPMC7247958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.